2-189043211-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000393.5(COL5A2):c.3411T>C(p.Gly1137Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.971 in 1,613,866 control chromosomes in the GnomAD database, including 762,338 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.96 ( 70265 hom., cov: 30)
Exomes 𝑓: 0.97 ( 692073 hom. )
Consequence
COL5A2
NM_000393.5 synonymous
NM_000393.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.09
Publications
22 publications found
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-189043211-A-G is Benign according to our data. Variant chr2-189043211-A-G is described in ClinVar as Benign. ClinVar VariationId is 1164098.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A2 | NM_000393.5 | c.3411T>C | p.Gly1137Gly | synonymous_variant | Exon 48 of 54 | ENST00000374866.9 | NP_000384.2 | |
| COL5A2 | XM_011510573.4 | c.3273T>C | p.Gly1091Gly | synonymous_variant | Exon 51 of 57 | XP_011508875.1 | ||
| COL5A2 | XM_047443251.1 | c.3273T>C | p.Gly1091Gly | synonymous_variant | Exon 53 of 59 | XP_047299207.1 | ||
| COL5A2 | XM_047443252.1 | c.3273T>C | p.Gly1091Gly | synonymous_variant | Exon 52 of 58 | XP_047299208.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A2 | ENST00000374866.9 | c.3411T>C | p.Gly1137Gly | synonymous_variant | Exon 48 of 54 | 1 | NM_000393.5 | ENSP00000364000.3 | ||
| COL5A2 | ENST00000618828.1 | c.2250T>C | p.Gly750Gly | synonymous_variant | Exon 41 of 47 | 5 | ENSP00000482184.1 |
Frequencies
GnomAD3 genomes AF: 0.960 AC: 146094AN: 152136Hom.: 70210 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
146094
AN:
152136
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.950 AC: 238595AN: 251182 AF XY: 0.956 show subpopulations
GnomAD2 exomes
AF:
AC:
238595
AN:
251182
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.973 AC: 1421624AN: 1461614Hom.: 692073 Cov.: 47 AF XY: 0.973 AC XY: 707732AN XY: 727110 show subpopulations
GnomAD4 exome
AF:
AC:
1421624
AN:
1461614
Hom.:
Cov.:
47
AF XY:
AC XY:
707732
AN XY:
727110
show subpopulations
African (AFR)
AF:
AC:
31679
AN:
33474
American (AMR)
AF:
AC:
37973
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
25403
AN:
26132
East Asian (EAS)
AF:
AC:
35144
AN:
39684
South Asian (SAS)
AF:
AC:
83824
AN:
86222
European-Finnish (FIN)
AF:
AC:
50926
AN:
53410
Middle Eastern (MID)
AF:
AC:
5557
AN:
5752
European-Non Finnish (NFE)
AF:
AC:
1092560
AN:
1111852
Other (OTH)
AF:
AC:
58558
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
1846
3693
5539
7386
9232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21646
43292
64938
86584
108230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.960 AC: 146207AN: 152252Hom.: 70265 Cov.: 30 AF XY: 0.959 AC XY: 71359AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
146207
AN:
152252
Hom.:
Cov.:
30
AF XY:
AC XY:
71359
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
39345
AN:
41544
American (AMR)
AF:
AC:
14050
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
3385
AN:
3472
East Asian (EAS)
AF:
AC:
4705
AN:
5170
South Asian (SAS)
AF:
AC:
4683
AN:
4820
European-Finnish (FIN)
AF:
AC:
10063
AN:
10614
Middle Eastern (MID)
AF:
AC:
287
AN:
294
European-Non Finnish (NFE)
AF:
AC:
66750
AN:
68024
Other (OTH)
AF:
AC:
2027
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
289
578
868
1157
1446
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3333
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
BA1 -
Ehlers-Danlos syndrome, classic type, 2 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.